A response to "Personalised medicine and population health: breast and ovarian cancer"

被引:12
作者
Antoniou, Antonis [1 ]
Anton-Culver, Hoda [2 ]
Borowsky, Alexander [3 ]
Broeders, Mireille [4 ]
Brooks, Jennifer [5 ]
Chiarelli, Anna [5 ]
Chiquette, Jocelyne [6 ]
Cuzick, Jack [7 ]
Delaloge, Suzette [8 ]
Devilee, Peter [9 ]
Dorval, Michael [6 ]
Easton, Douglas [1 ]
Eisen, Andrea [10 ]
Eklund, Martin [11 ]
Eloy, Laurence [6 ]
Esserman, Laura [12 ]
Garcia-Closas, Montserrat [13 ]
Goldgar, David [14 ]
Hall, Per [11 ]
Knoppers, Bartha Maria [15 ]
Kraft, Peter [16 ]
La Croix, Andrea [17 ]
Madalensky, Lisa [17 ]
Mavaddat, Nasim [1 ]
Mittman, Nicole [18 ]
Nabi, Hermann [6 ]
Olopade, Olufunmilayo [19 ]
Pashayan, Nora [20 ]
Schmidt, Marjanka [21 ]
Shieh, Yiwey [12 ]
Simard, Jacques [6 ]
Stover-Fiscallini, Allison [12 ]
Tice, Jeffrey A. [12 ]
van't Veer, Laura [12 ]
Wenger, Neil [22 ]
Wolfson, Michael [23 ]
Yau, Christina [12 ]
Ziv, Elad [12 ]
机构
[1] Univ Cambridge, Cambridge, England
[2] Univ Calif Irvine, Irvine, CA USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[5] Univ Toronto, Toronto, ON, Canada
[6] Univ Laval, Quebec City, PQ, Canada
[7] Queen Mary Univ London, London, England
[8] Inst Gustave Roussy, Villejuif, France
[9] Leiden Univ, Leiden, Netherlands
[10] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[11] Karolinska Inst, Stockholm, Sweden
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] NCI, Bethesda, MD 20892 USA
[14] Univ Utah, Salt Lake City, UT USA
[15] McGill Univ, Montreal, PQ, Canada
[16] Harvard Univ, Cambridge, MA 02138 USA
[17] Univ Calif San Diego, San Diego, CA 92103 USA
[18] Sunnybrook Res Inst, Toronto, ON, Canada
[19] Univ Chicago, Chicago, IL 60637 USA
[20] UCL, London, England
[21] Netherlands Canc Inst, Amsterdam, Netherlands
[22] Univ Calif Los Angeles, Los Angeles, CA USA
[23] Univ Ottawa, Ottawa, ON, Canada
关键词
D O I
10.1007/s00439-019-01984-z
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
引用
收藏
页码:287 / 289
页数:3
相关论文
共 11 条
[1]
Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial [J].
Chlebowski, RT ;
Hendrix, SL ;
Langer, RD ;
Stefanick, ML ;
Gass, M ;
Lane, D ;
Rodabough, RJ ;
Gilligan, MA ;
Cyr, MG ;
Thomson, CA ;
Khandekar, J ;
Petrovitch, H ;
McTiernan, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24) :3243-3253
[2]
Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study [J].
Cuzick, Jack ;
Warwick, Jane ;
Pinney, Elizabeth ;
Duffy, Stephen W. ;
Cawthorn, Simon ;
Howell, Anthony ;
Forbes, John F. ;
Warren, Ruth M. L. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (09) :744-752
[3]
The WISDOM Study: breaking the deadlock in the breast cancer screening debate [J].
Esserman, Laura J. .
NPJ BREAST CANCER, 2017, 3
[4]
Genome Canada, 2018, PERS RISK ASS PREV E
[5]
Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer [J].
Li, Jingmei ;
Humphreys, Keith ;
Eriksson, Louise ;
Edgren, Gustaf ;
Czene, Kamila ;
Hall, Per .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18) :2249-U50
[6]
Nyante SJ, 2015, JNCI
[7]
Pashayan N, 2018, JAMA ONCOL
[8]
The decrease in breast-cancer incidence in 2003 in the United States. [J].
Ravdin, Peter M. ;
Cronin, Kathleen A. ;
Howlader, Nadia ;
Berg, Christine D. ;
Chlebowski, Rowan T. ;
Feuer, Eric J. ;
Edwards, Brenda K. ;
Berry, Donald A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (16) :1670-1674
[9]
Rosenberg-Wohl S, 2017, PRIVATE PAYER PARTIC
[10]
UK Department of Health and Social Care, 2018, PREV IS BETT CUR OUR